NHS Framework Agreement - North of England - Tranche B

NHS EnglandcontractContracts Finder ↗Ref tender_151219/653577SME suitablecomplete

Estimated value

£521.1m

Awarded value

£521.1m

Awarded 08 Jan 2018

Suppliers

1

Lots

1

1 awarded

Published

19 Apr 2018

Deadline 07 Nov 2017

Awarded suppliers· 1 supplier

Awarded 08 Jan 2018 · Contract period 01 Mar 2018 — 29 Feb 2020

Award value

£521.1m

1

AP

ASTELLAS PHARMA LTD.,AVENTIS PHARMA LIMITED T/A SANOFI,BAYER PUBLIC LIMITED COMPANY,BIOGEN IDEC LIMITED,OEHRINGER INGELHEIM LIMITED,BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED,DAIICHI SANKYO UK LIMITED,ELI LILLY AND COMPANY LIMITED,FERRING PHARMACEUTICALS LIMITED,GEDEON RICHTER (UK) LIMITED,GENZYME THERAPEUTICS LIMITED,GILEAD SCIENCES LTD,INTRAPHARM LABORATORIES LIMITED,IPSEN LIMITED,JANSSEN-CILAG LIMITED,LEOPHARMA LIMITED,MERCK SERONO LIMITED,MERCURY PHARMACEUTICALS LIMITED,MERCK SHARP & DOHME LIMITED,NAPP PHARMACEUTICALS LIMITED,NOVARTIS PHARMACEUTICALS UK LIMITED,NOVO NORDISK LIMITED,PFIZER LIMITED,PHARMASURE LIMITED,ROCHE PRODUCTS LIMITED,ROVI BIOTECH LIMITED,SANDOZ LIMITED,TAKEDA UK LIMITED,TEVA UK LIMITED,UCB PHARMA LIMITED